Certified by Founder Lodge
Myricx Bio

START UP
1 Disclosed Funding Rounds $115,246,800
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-
Date | Round | Raised | Participating Investors |
---|---|---|---|
July, 09 ,2024 | Series A | $115,246,800 |